BioFlorida, Florida’s life sciences association, will host the state’s life science industry during the 16th Annual Life Sciences Conference, Sept. 15–17, 2013 at the Tampa Marriott Waterside. Building on the Conference theme “Collaboration Makes Innovation Happen,” attendees from Florida and across the nation will converge in Tampa to hear about scientific innovations, new business ventures, federal and state legislation, and regulatory environment. Additionally, companies will have the opportunity to pitch venture capitalists and angel investors on their innovative technologies, products and business models, share their successes and discuss collaborative opportunities.
“This event is designed for the business leader, entrepreneur, engineer or scientist who wants to take a great idea and make it a commercial success.”
“This year’s Conference is very exciting and extremely comprehensive. The program has been expanded to incorporate all of Florida’s life sciences including biotech, pharma, medical device and bioagriculture,” said Nancy Bryan, president and CEO of BioFlorida. “Our goal is to bring together scientists, executives, investors, entrepreneurs and law makers to share challenges and opportunities that will fuel the continued growth of life sciences in Florida. We are thrilled to welcome participants to Tampa for the 2013 Conference, as this region is home to many of our state’s life science organizations that support research and entrepreneurial activity including the H. Lee Moffitt Cancer Center & Research Institute, the University of South Florida Center For Advanced Medical Learning and Simulation (CAMLS) and the Lions Eye Institute for Transplant & Research.”
One of the most successful biotech company entrepreneurs in the U.S., Randal J. Kirk, Chairman and CEO of Intrexon Corporation, a biotechnology company, will deliver Monday’s opening keynote. U.S. Representative Kathy Castor, 14th District of Florida, will provide remarks about the future of drug approvals in the U.S., and Stephen B. Liggett, MD, vice dean for research and vice dean for personalized medicine and genomics at USF’s Morsani College of Medicine will present “Resurrecting Failed Drugs Using Genomics: The Case of Bucindolol.” Members of the Florida state legislature including Representative Matt Hudson (R-80) will close Monday’s sessions with a panel discussion on the impact of state government on the biosciences.
Chief Financial Officer Jeff Atwater will open Tuesday’s session with a discussion of the business climate in Florida and the importance of venture capital to the continued growth of new, Florida-based companies. W. P. Andrew Lee, MD, the Milton T. Edgerton, MD Professor and Director of the Department of Plastic and Reconstructive Surgery at Johns Hopkins and a pioneer in hand transplants will present “The Promises and Challenges of Hand Transplantation,” and close the Conference.
“Innovation and entrepreneurship are key drivers of the life sciences, and we are pleased to announce a Pre-Conference event on Sunday afternoon called ‘Innovation Forum’ that will help harness these two powerful forces and support the advancement of life sciences in Florida,” said Deborah Sutherland, PhD, chairman of the BioFlorida state Conference and CEO of USF CAMLS. “This event is designed for the business leader, entrepreneur, engineer or scientist who wants to take a great idea and make it a commercial success.”
Jointly presented by BioFlorida and USF CAMLS, the Innovation Forum will be held on the CAMLS campus. The event will be moderated by Stuart Hart, MD, FACOG, FACS, director of CAMLS’ Tampa Bay Research and Innovation Center, and will feature key opinion leaders and industry experts including Peter B. Angood, MD, FRCS(C), FACS, FCCM, CEO of American College of Physician Executives; Leonard Polizzotto, vice president, marketing and strategic business development of Draper Laboratory; and Wendy Kennedy, founder and CEO of WKI. One of the Pre-Conference activities will include an interactive activity to show participants how visual models and tools will help transform unique and complex scientific and technical innovations into clear and compelling business value propositions.
The general Conference program will include four tracks: BioInvesting, BioBusiness, BioScience and BioTrends.
The BioInvesting Track will include:
- a medical device investor forum;
- Find it, Fund It, Develop It: Corporate Relationships to Bring Your Pharma Product to Market;
- BioPitch: early-, mid- and late-stage company presentations to angels and investors.
The BioBusiness Track will include:
- implementation of the America Invents Act and other recent developments in U.S. patent law;
- venture philanthropy;
- what medical device companies are looking for in licensing, partnership and acquisition;
- macro to micro needs for a new lab facility.
The BioScience Track will include:
- promoting innovation through collaboration at the interface of technology and medicine;
- the role of fisheries and aquaculture in providing sustainable seafood for Florida;
- aging, memory and dementia;
- bioengineering: an industry and clinical interface;
- translational research leading to state-of-the-art care for our veterans.
The BioTrends Track will include:
- personalized medicine: a look at disruptive new technologies;
- innovative companies in Florida;
- the rising tide of big data in healthcare and biotech;
- driving product innovation: collaboration with manufacturers
The full list of speakers and additional details about their presentation topics will be announced in August. For more information or to register for BioFlorida’s 16thAnnual Conference, visit BioFlorida.com/Conference. Follow the Conference activities on social media using #BioFLConf.